
08/30/2025
Artificial intelligence technologies are rapidly transforming the field of plastic surgery, offering new opportunities for improving patient outcomes through enhanced diagnostic capabilities, personalized treatment planning, and outcome prediction. However, the integration of these technologies into clinical practice requires navigation of complex regulatory frameworks established by the US Food and Drug Administration.
This review outlines the current FDA regulatory pathways relevant to AI applications in plastic surgery.
Read now: https://doi.org/10.1093/asj/sjaf051